180 Wealth Advisors LLC Sells 231 Shares of Intuitive Surgical, Inc. $ISRG

180 Wealth Advisors LLC reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.0% during the 2nd quarter, HoldingsChannel reports. The firm owned 3,620 shares of the medical equipment provider’s stock after selling 231 shares during the quarter. 180 Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $1,967,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Norway Savings Bank grew its holdings in Intuitive Surgical by 53.4% in the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after buying an additional 910 shares during the last quarter. IronOak Wealth LLC. acquired a new position in shares of Intuitive Surgical during the second quarter worth approximately $1,099,000. Trust Co. of Oklahoma bought a new stake in shares of Intuitive Surgical in the second quarter valued at approximately $363,000. Neville Rodie & Shaw Inc. grew its stake in shares of Intuitive Surgical by 11.9% in the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock worth $5,666,000 after acquiring an additional 1,110 shares during the last quarter. Finally, Sax Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 218.1% in the second quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock worth $1,334,000 after acquiring an additional 1,684 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $551.30 on Friday. The stock has a market cap of $197.63 billion, a PE ratio of 72.92, a PEG ratio of 5.53 and a beta of 1.61. The business has a fifty day moving average of $456.77 and a two-hundred day moving average of $496.40. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 earnings per share. Analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the transaction, the director owned 739 shares in the company, valued at $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 40,724 shares of company stock valued at $19,500,332. 0.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms recently commented on ISRG. UBS Group set a $600.00 target price on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Thursday. Sanford C. Bernstein restated an “outperform” rating and set a $685.00 price objective on shares of Intuitive Surgical in a report on Tuesday. Evercore ISI cut their price objective on shares of Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research report on Tuesday, October 7th. Royal Bank Of Canada set a $625.00 target price on Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday. Finally, BTIG Research upped their price target on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a report on Wednesday. Eighteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $604.50.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.